FI70670C - Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel - Google Patents

Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel Download PDF

Info

Publication number
FI70670C
FI70670C FI810934A FI810934A FI70670C FI 70670 C FI70670 C FI 70670C FI 810934 A FI810934 A FI 810934A FI 810934 A FI810934 A FI 810934A FI 70670 C FI70670 C FI 70670C
Authority
FI
Finland
Prior art keywords
cisplatin
solution
polyethylene glycol
solutions
room temperature
Prior art date
Application number
FI810934A
Other languages
English (en)
Finnish (fi)
Other versions
FI810934L (fi
FI70670B (fi
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI810934L publication Critical patent/FI810934L/fi
Application granted granted Critical
Publication of FI70670B publication Critical patent/FI70670B/fi
Publication of FI70670C publication Critical patent/FI70670C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI810934A 1980-03-31 1981-03-26 Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel FI70670C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31
US13537380 1980-03-31

Publications (3)

Publication Number Publication Date
FI810934L FI810934L (fi) 1981-10-01
FI70670B FI70670B (fi) 1986-06-26
FI70670C true FI70670C (fi) 1986-10-06

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810934A FI70670C (fi) 1980-03-31 1981-03-26 Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel

Country Status (30)

Country Link
JP (1) JPS56152415A (it)
KR (1) KR860000841B1 (it)
AR (1) AR225500A1 (it)
AT (1) AT370996B (it)
AU (1) AU541056B2 (it)
BE (1) BE888209A (it)
CA (1) CA1162479A (it)
CH (1) CH647481A5 (it)
CS (1) CS246051B2 (it)
DD (1) DD157762A5 (it)
DE (1) DE3112272A1 (it)
DK (1) DK158564C (it)
ES (1) ES500869A0 (it)
FI (1) FI70670C (it)
FR (1) FR2480605A1 (it)
GB (1) GB2074028B (it)
GR (1) GR72769B (it)
HU (1) HU183379B (it)
IE (1) IE51070B1 (it)
IL (1) IL62517A (it)
IT (1) IT1170838B (it)
LU (1) LU83270A1 (it)
NL (1) NL8101531A (it)
NO (1) NO156675C (it)
NZ (1) NZ196519A (it)
PH (1) PH17152A (it)
PT (1) PT72774B (it)
SE (1) SE455045B (it)
SU (1) SU1056893A3 (it)
ZA (1) ZA812084B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (it) 1984-05-11
DE3112272C2 (it) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (it) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (it) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
US4322391A (en) Process for the preparation of microcrystalline cisplatin
FI78236B (fi) Foerfarande foer framstaellning av en frystorkad doseringsenhet av cis-platina (ii) diamindiklorid.
US4310515A (en) Pharmaceutical compositions of cisplatin
FI90204B (fi) Menetelmä injektoitavan melfalaanikoostumuksen valmistamiseksi
KR100351713B1 (ko) 백금(ii) 항종양제의 안정용액
CN1154654A (zh) 一种药学上稳定的奥沙利铂制剂
KR20010041182A (ko) 배합물
FI70670C (fi) Foerfarande foer framstaellning av en stabil koncentrerad cisplatin-loesning i ett loesningsmedel
FI66121B (fi) Foerfarande foer framstaellning av en stabil vattenloesning avisplatin
EP0397147B1 (en) Stable solutions of rebeccamycin analog and preparation thereof
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
KR20060072146A (ko) 안트라퀴논 유도체의 제형
IE51468B1 (en) Microcrystalline cisplatin and formulations containing it

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS CO